Sage Therapeutics, Inc. Announces Departure of Mike Cloonan as Chief Operating Officer, Effective May 3, 2021
March 16, 2021 at 08:45 pm
Sage Therapeutics announced that Mike Cloonan, Sage’s Chief Operating Officer, is leaving the company effective May 3, 2021 to pursue other opportunities. The Company will not seek to immediately fill the position. Mike’s responsibilities will be assumed by the CEO, with Mike’s support during the transition, as Sage continues planned expansion and acceleration initiatives on its mission to deliver innovative medicines for brain health disorders.